Possible role of hypercoagulability in calciphylaxis: Review of the literature

Journal of the American Academy of Dermatology

Volumn 64, Issue 2, 2011, Pages 405-412

  Harris, Ryan Jeffrey ^a   Cropley, Thomas George ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

calciphylaxis; clotting disorder; end stage renal disease; hypercoagulable; protein C; protein S

Indexed keywords

AMPICILLIN; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; PSEUDOMONIC ACID; SULBACTAM; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN; ZINC OXIDE;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CALCINOSIS; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; LEG ULCER; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN CONTENT; PROTEIN S DEFICIENCY; SKIN DEFECT; SKIN ULCER; SYSTEMATIC REVIEW;

EID: 78751571218     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.12.007     Document Type: Review

References (34)

1. S.U. Nigwekar, M. Wolf, R.H. Sterns, and J.K. Hix Calciphylaxis from nonuremic causes: a systematic review Clin J Am Soc Nephrol 3 2008 1139 1143
2. S.M. Chavel, K.S. Taraszka, J.V. Schaffer, R. Lazova, and J.S. Schechner Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis J Am Acad Dermatol 50 Suppl 2004 S125 S128
3. J.P. Banky, J.P. Dowling, and C. Miles Idiopathic calciphylaxis Australas J Dermatol 43 2002 190 193
4. M. Hachicha, J. Champigneulle, N. Cordebar, and M. Kessler Necrotic ulceration during hemodialysis Clin Exp Dermatol 29 2004 695 696
5. T.M. Jelic, A.M. Malas, S.S. Groves, B. Jin, P.F. Mellen, and G. Osborne Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure South Med J 97 2004 194 198
6. L.D. Sewell, R.H. Weenig, M.D. Davis, M.T. McEvoy, and M.R. Pittelkow Low-dose tissue plasminogen activator for calciphylaxis Arch Dermatol 140 2004 1045 1048
7. R.L. Galimberti, R. Farias Edos, I.H. Parra, L. Algranati, A. Kowalczuk, and N. Imperiali Cutaneous necrosis by calcific uremic arteriolopathy Int J Dermatol 44 2005 101 106
8. A.K. Goli, S.A. Goli, L.S. Shah, R.P. Byrd Jr., and T.M. Roy Calciphylaxis: a rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause? South Med J 98 2005 736 739
9. A.A. Imam, T.K. Mattoo, G. Kapur, D.A. Bloom, and R.P. Valentini Calciphylaxis in pediatric end-stage renal disease Pediatr Nephrol 20 2005 1776 1780
10. C.E. Araya, R.S. Fennell, R.E. Neiberger, and V.R. Dharnidharka Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults Clin J Am Soc Nephrol 1 2006 1161 1166
11. J.R. Ferreres, J. Marcoval, X. Bordas, A. Moreno, C. Muniesa, and C. Prat Calciphylaxis associated with alcoholic cirrhosis J Eur Acad Dermatol Venereol 20 2006 599 601
12. K.G. Lewis, B.W. Lester, T.D. Pan, and L. Robinson-Bostom Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum-like changes J Cutan Pathol 33 2006 695 700
13. Y.J. Li, Y.C. Tian, Y.C. Chen, S.F. Huang, C.C. Huang, and J.T. Fang Fulminant pulmonary calciphylaxis and metastatic calcification causing acute respiratory failure in a uremic patient Am J Kidney Dis 47 2006 e47 e53
14. N. Shiraishi, K. Kitamura, T. Miyoshi, M. Adachi, Y. Kohda, and H. Nonoguchi Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium Am J Kidney Dis 48 2006 151 154
15. K. Brouns, E. Verbeken, H. Degreef, H. Bobbaers, and D. Blockmans Fatal calciphylaxis in two patients with giant cell arteritis Clin Rheumatol 26 2007 836 840
16. V.C. Kyttaris, S. Timbil, D. Kalliabakos, G. Vaiopoulos, and A. Weinstein Calciphylaxis: a pseudo-vasculitis syndrome Semin Arthritis Rheum 36 2007 264 267
17. G. Aabed, O. Al Furayh, A. Al-Lehbi, H. Al Mana, A. Al Ghamedi, and A. Helmy Calciphylaxis-associated second renal graft failure and patient loss: a case report and review of the literature Exp Clin Transplant 6 2008 287 293
18. N. Asobie, E. Wong, and M.G. Cook Calciphylaxis in a diabetic patient provoked by warfarin therapy Clin Exp Dermatol 33 2008 342 344
19. K. Subramaniam, H. Wallace, R. Sinniah, and B. Saker Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate Australas J Dermatol 49 2008 30 34
20. A. Almafragi, J. Vandorpe, and K. Dujardin Calciphylaxis in a cardiac patient without renal disease Acta Cardiol 64 2009 91 93
21. A.H. Kalajian, P.S. Malhotra, J.P. Callen, and L.P. Parker Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed Arch Dermatol 145 2009 451 458
22. A.M. Swanson, S.R. Desai, J.D. Jackson, A.A. Andea, and L.C. Hughey Calciphylaxis associated with chronic inflammatory conditions, immunosuppression therapy, and normal renal function: a report of 2 cases Arch Dermatol 145 2009 723 725
23. T. Coates, G.S. Kirkland, R.B. Dymock, B.F. Murphy, J.K. Brealey, and T.H. Mathew Cutaneous necrosis from calcific uremic arteriolopathy Am J Kidney Dis 32 1998 384 391
24. D.L. Riegert-Johnson, J.S. Kaur, and E.A. Pfeifer Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K Mayo Clin Proc 76 2001 749 752
25. R. Perez-Mijares, J.L. Guzman-Zamudio, J. Payan-Lopez, A. Rodriguez-Fernandez, P. Gomez-Fernandez, and M. Almaraz-Jimenez Calciphylaxis in a hemodialysis patient: functional protein S deficiency? Nephrol Dial Transplant 11 1996 1856 1859 (Pubitemid 26297581)
26. J.J. Wong, A. Laumann, and M. Martinez Calciphylaxis and antiphospholipid antibody syndrome J Am Acad Dermatol 42 2000 849
27. S. Sankarasubbaiyan, G. Scott, and J.L. Holley Cryofibrinogenemia: an addition to the differential diagnosis of calciphylaxis in end-stage renal disease Am J Kidney Dis 32 1998 494 498
28. W.A. Wilmer, and C.M. Margo Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment Semin Dial 15 2002 172 186
29. R.H. Weenig, L.D. Sewell, M.D. Davis, J.T. McCarthy, and M.R. Pittelkow Calciphylaxis: natural history, risk factor analysis, and outcome J Am Acad Dermatol 56 2007 569 579
30. R.H. Weenig Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B J Am Acad Dermatol 58 2008 458 471
31. R.L. Mehta, G. Scott, J.A. Sloand, and C.W. Francis Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis Am J Med 88 1990 252 257
32. K.N. Lai, J.A. Yin, P.M. Yuen, and P.K. Li Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis Nephron 56 1990 271 276
33. K.S. Kant, H.I. Glueck, M.C. Coots, V.A. Tonne, R. Brubaker, and I. Penn Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis Am J Kidney Dis 19 1992 264 271
34. D.J. Goldsmith Calciphylaxis, thrombotic diathesis and defects in coagulation regulation Nephrol Dial Transplant 12 1997 1082 1083